BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND BRD3, KIAA0043, 8019, ENSG00000169925, Q15059, ORFX, RING3L AND Treatment
6 results:

  • 1. A Phase I/II Study of GSK525762 Combined with Fulvestrant in Patients with Hormone Receptor-positive/HER2-negative Advanced or Metastatic breast cancer.
    Cescon DW; Hilton J; Morales Murilo S; Layman RM; Pluard T; Yeo B; Park IH; Provencher L; Kim SB; Im YH; Wyce A; Krishnatry AS; Hicks K; Zhang Q; Barbash O; Khaled A; Horner T; Dhar A; Oliveira M; Sparano JA
    Clin Cancer Res; 2024 Jan; 30(2):334-343. PubMed ID: 37992310
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Racial disparities in mortality outcomes among women diagnosed with breast cancer in Maryland: Impact of cardiovascular disease and clinical characteristics.
    Connor AE; Kaur M; Sheng JY; Hayes JH
    Cancer; 2022 Feb; 128(4):727-736. PubMed ID: 34873682
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Distinct Roles for BET Family Members in Estrogen Receptor α Enhancer Function and Gene Regulation in breast cancer Cells.
    Murakami S; Li R; Nagari A; Chae M; Camacho CV; Kraus WL
    Mol Cancer Res; 2019 Dec; 17(12):2356-2368. PubMed ID: 31551256
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. BET Inhibition as a Rational Therapeutic Strategy for Invasive Lobular breast cancer.
    Walsh L; Haley KE; Moran B; Mooney B; Tarrant F; Madden SF; Di Grande A; Fan Y; Das S; Rueda OM; Dowling CM; Varešlija D; Chin SF; Linn S; Young LS; Jirström K; Crown JP; Bernards R; Caldas C; Gallagher WM; O'Connor DP; Ní Chonghaile T
    Clin Cancer Res; 2019 Dec; 25(23):7139-7150. PubMed ID: 31409615
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Metabolic Response to XD14 treatment in Human breast cancer Cell Line MCF-7.
    Pan D; Kather M; Willmann L; Schlimpert M; Bauer C; Lagies S; Schmidtkunz K; Eisenhardt SU; Jung M; Günther S; Kammerer B
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27783056
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. An epigenomic approach to therapy for tamoxifen-resistant breast cancer.
    Feng Q; Zhang Z; Shea MJ; Creighton CJ; Coarfa C; Hilsenbeck SG; Lanz R; He B; Wang L; Fu X; Nardone A; Song Y; Bradner J; Mitsiades N; Mitsiades CS; Osborne CK; Schiff R; O'Malley BW
    Cell Res; 2014 Jul; 24(7):809-19. PubMed ID: 24874954
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.